Date(s) - 9 Apr 2019 until 10 Apr 2019
8:00 AM - 5:00 PM
Hilton El Conquistador
April 9 -10, 2019
El Conquistador Tucson, Arizona
Now in its 15th year, the annual Tucson Symposium brings together more than 500 thought leaders including pathologists, oncologists and other researchers in cancer from around the world to explore the pivotal role that translational research plays in improving our understanding and treatment of cancer.
Sponsored by Roche Tissue Diagnostics, the Tucson Symposium 2019 (TS19) invites you to join us for two days in Tucson, Arizona to debate new findings, discuss evolving theories and learn about innovative diagnostics and new outcomes in treatments that can significantly impact medical practice. TS19 will cover a diverse range of topics including immunology, tumor heterogeneity, translational medicine, new frontiers in colorectal cancer, informatics and transforming technologies with the singular focus of improving patients’ lives.
With tremendous scientific and technological advancements, our understanding of cancer expands by the day, bringing with it an ever-increasing number of potential options to treat cancer patients. Determining which treatment regimens to use in each individual patient for the best possible outcomes has become more complex and requires us to accelerate our evolution of knowledge and understanding.
Cross-discipline collaboration among the world’s cancer experts is critical in reaching our goals of conquering cancer and improving patients’ lives. This information sharing is a cornerstone of Tucson Symposium, sponsored by Ventana Medical Systems, Inc., a member of the Roche Group. The meeting annually draws more than 500 pathologists, oncologists, scientific researchers and healthcare leaders from around the globe to present the latest scientific data, explore cutting-edge scientific concepts and hypotheses and discuss breakthroughs in cancer research, diagnosis and treatment.